Market Place
Sourcing Support
Ferrer offers $122M biobucks for ex-US license to Verge ALS drug
25 Mar 2024 //
PRESS RELEASE
Verge Genomics to Present at Evercore ISI 2024 Emerging Biotech Conference
21 Feb 2024 //
GLOBENEWSWIRE
Verge Genomics Announces Initiation of Study for ALS with VRG50635
09 Jan 2024 //
GLOBENEWSWIRE
Verge Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
GLOBENEWSWIRE
Verge Genomics Will Use Modality.AI in ALS Phase 1b Clinical Trial of VRG50635
29 Nov 2023 //
GLOBENEWSWIRE
Verge Genomics teams up with AstraZeneca in drug discovery deal
09 Sep 2023 //
ENDPTS
Verge Genomics Announces Positive Safety Data from the Phase 1 Trial of VRG50635
15 Jun 2023 //
BUSINESSWIRE
Verge Genomics to Present at Mass General Brigham Medical Innovation Forum
05 Jun 2023 //
BUSINESSWIRE
Verge Genomics Appoints Diego Cadavid, M.D., as Chief Medical Officer
06 Dec 2022 //
BUSINESSWIRE
Verge Genomics to Present at Upcoming Investor Conferences in November
21 Nov 2022 //
BUSINESSWIRE
Alice Zhang Recognized as a Pioneer in AI-Driven Drug Discovery
14 Nov 2022 //
BUSINESSWIRE
Verge Genomics Initiates First-In-Human Dosing in Phase 1 Trial of VRG50635
31 Oct 2022 //
BUSINESSWIRE
Verge Genomics takes AI-sourced drug for ALS into clinic
31 Oct 2022 //
PHARMAPHORUM
Verge Genomics Appoints John Applegate as Chief Financial Officer
17 Oct 2022 //
BUSINESSWIRE
Verge Genomics Secures $98 Million in New Financing
16 Dec 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.